Scientific article
French

Transplantation de pancréas et d'ilôts de Langerhans: le point en 2009 et le futur

Published inRevue médicale suisse, vol. 5, no. 206, p. 1266-1270,1272
Publication date2009
Abstract

Type 1 diabetes currently affects 15,000 patients in Switzerland with a rising incidence worldwide. Pancreas or islet of Langerhans transplantation are alternatives to intensive insulin treatment, which decreases long-term complications at the cost of an increase of severe hyoglycemia. Pancreas transplantation, indicated mainly to diabetic patients with simultaneous kidney transplantation, has a high success rate, but is accompanied by high morbidity due to general surgery. Islet transplantation, a cell-therapy for type 1 diabetes, is in full development. It is mainly indicated as islet transplant alone in patients suffering from brittle diabetes, and is associated with a very low risk due to minimally invasive technique, but a lower rate of long-term success. New potential sources of beta cell replacement are beta-cell lines, stem cells and xenotransplantation.

Keywords
  • Diabetes Mellitus, Type 1/surgery
  • Humans
  • Islets of Langerhans Transplantation
  • Pancreas Transplantation
Citation (ISO format)
NICLAUSS, Nadja et al. Transplantation de pancréas et d’ilôts de Langerhans: le point en 2009 et le futur. In: Revue médicale suisse, 2009, vol. 5, n° 206, p. 1266–1270,1272.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Additional URL for this publicationhttp://rms.medhyg.ch/numero-206-page-1266.htm
Journal ISSN1660-9379
629views
0downloads

Technical informations

Creation31/10/2013 13:18:00
First validation31/10/2013 13:18:00
Update time14/03/2023 20:45:10
Status update14/03/2023 20:45:10
Last indexation30/10/2024 15:29:19
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack